BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11340659)

  • 1. Mechanism of NAD(P)H:quinone reductase: Ab initio studies of reduced flavin.
    Cavelier G; Amzel LM
    Proteins; 2001 Jun; 43(4):420-32. PubMed ID: 11340659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, function, and mechanism of cytosolic quinone reductases.
    Bianchet MA; Erdemli SB; Amzel LM
    Vitam Horm; 2008; 78():63-84. PubMed ID: 18374190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction.
    Li R; Bianchet MA; Talalay P; Amzel LM
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8846-50. PubMed ID: 7568029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiometric and further kinetic characterization of the flavin-binding domain of Saccharomyces cerevisiae flavocytochrome b2. Inhibition by anions binding in the active site.
    Cénas N; Lê KH; Terrier M; Lederer F
    Biochemistry; 2007 Apr; 46(15):4661-70. PubMed ID: 17373777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
    Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
    Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical determination of the redox potentials of NRH:quinone oxidoreductase 2 using quantum mechanical/molecular mechanical simulations.
    Rauschnot JC; Yang C; Yang V; Bhattacharyya S
    J Phys Chem B; 2009 Jun; 113(23):8149-57. PubMed ID: 19445526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein dynamics and electrostatics in the function of p-hydroxybenzoate hydroxylase.
    Entsch B; Cole LJ; Ballou DP
    Arch Biochem Biophys; 2005 Jan; 433(1):297-311. PubMed ID: 15581585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of human quinone reductase type 2, a metalloflavoprotein.
    Foster CE; Bianchet MA; Talalay P; Zhao Q; Amzel LM
    Biochemistry; 1999 Aug; 38(31):9881-6. PubMed ID: 10433694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase).
    Zhao Q; Yang XL; Holtzclaw WD; Talalay P
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1669-74. PubMed ID: 9050836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the flavin reductase component (HpaC) of 4-hydroxyphenylacetate 3-monooxygenase from Thermus thermophilus HB8: Structural basis for the flavin affinity.
    Kim SH; Hisano T; Iwasaki W; Ebihara A; Miki K
    Proteins; 2008 Feb; 70(3):718-30. PubMed ID: 17729270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavin conformational changes in the catalytic cycle of p-hydroxybenzoate hydroxylase substituted with 6-azido- and 6-aminoflavin adenine dinucleotide.
    Palfey BA; Ballou DP; Massey V
    Biochemistry; 1997 Dec; 36(50):15713-23. PubMed ID: 9398300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic and docking studies of the interaction of quinones with the quinone reductase active site.
    Zhou Z; Fisher D; Spidel J; Greenfield J; Patson B; Fazal A; Wigal C; Moe OA; Madura JD
    Biochemistry; 2003 Feb; 42(7):1985-94. PubMed ID: 12590585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure--function studies on the iron-sulfur flavoenzyme glutamate synthase: an unexpectedly complex self-regulated enzyme.
    Vanoni MA; Curti B
    Arch Biochem Biophys; 2005 Jan; 433(1):193-211. PubMed ID: 15581577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of NAD(P)H:flavin oxidoreductase from Escherichia coli.
    Ingelman M; Ramaswamy S; Nivière V; Fontecave M; Eklund H
    Biochemistry; 1999 Jun; 38(22):7040-9. PubMed ID: 10353815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of NAD(P)H:quinone acceptor oxidoreductase by flavones: a structure-activity study.
    Chen S; Hwang J; Deng PS
    Arch Biochem Biophys; 1993 Apr; 302(1):72-7. PubMed ID: 8470908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for flavin movement in the function of p-hydroxybenzoate hydroxylase from studies of the mutant Arg220Lys.
    Moran GR; Entsch B; Palfey BA; Ballou DP
    Biochemistry; 1996 Jul; 35(28):9278-85. PubMed ID: 8703933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and mechanism of NAD[P]H:quinone acceptor oxidoreductases (NQO).
    Bianchet MA; Faig M; Amzel LM
    Methods Enzymol; 2004; 382():144-74. PubMed ID: 15047101
    [No Abstract]   [Full Text] [Related]  

  • 19. Reaction of the NAD(P)H:flavin oxidoreductase from Escherichia coli with NADPH and riboflavin: identification of intermediates.
    Nivière V; Vanoni MA; Zanetti G; Fontecave M
    Biochemistry; 1998 Aug; 37(34):11879-87. PubMed ID: 9718311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.